Frontlight ResearchEarly access
Trial site
East Texas Cardiology PA
- 6running trials
- 2closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Heart failure4 trials
- Coronary artery disease3 trials
- Obesity2 trials
- Atrial fibrillation1 trial
- Familial hypercholesterolaemia1 trial
- Stroke1 trial
- Phase
- Phase 36 trials
- Phase 21 trial
- Status
- Recruiting4 trials
- Active, not recruiting2 trials
- Completed2 trials
- Lead sponsor
- Amgen2 trials
- Janssen Research & Development, LLC2 trials
- Novo Nordisk A/S2 trials
- Novartis Pharmaceuticals1 trial
- Vifor (International) Inc.1 trial
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure3 recruiting
- Obesity2 recruiting
- Coronary artery disease1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026